You are here

  • Home
  • Archive
  • Volume 5, Issue 6
  • Review: pharmacological interventions are more effective than non-pharmacological for attention deficit hyperactivity disorder

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: pharmacological interventions are more effective than non-pharmacological for attention deficit hyperactivity disorder

https://doi.org/10.1136/ebm.5.6.179

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    . Jadad AR, Boyle M, Cunningham C, et al. Treatment of attention-deficit/hyperactivity disorder. Evid Rep Technol Assess (Summ) 1999 Nov:1–341. http://www.ahcpr.gov..

    
 
 QUESTIONS: In patients with attention deficit hyperactivity disorder (ADHD), what are the short term and long term effectiveness and safety of pharmacological and non-pharmacological interventions? Are combined interventions more effective than single interventions?

    Data sources

    Studies were identified by searching Medline (1966–97), CINAHL (1982–97), PsycINFO (1984–97), EMBASE/Excerpta Medica (1984–97), and the Cochrane Library and by reviewing references of relevant studies, web sites of organisations funding research on ADHD, and files of research team members and partner organisations.

    Study selection

    Studies were selected if they were randomised controlled trials (RCTs) of treatment for ADHD published in peer reviewed journals. Specific interventions considered were drug compared with drug (methylphenidate, dextroamphetamine, and pemoline), placebo compared with tricyclic antidepressant, drug compared with non-drug, combination treatments, long term treatments (≥12 wks), treatments for ADHD in adults, and adverse effects.

    Data extraction

    Data were extracted by 2 independent reviewers on 41 study elements, including methodological quality, study design attributes, funding, patient characteristics, sampling issues, diagnosis, …

    View Full Text

    Footnotes

    • Source of funding: US Agency for Healthcare Research and Quality.

    • For correspondence: Dr A R Jadad, McMaster University, Health Sciences Centre, Room 3H7, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada.